Grover Berryhill, PA
Medical · Benson, NCNPI 1528316635
Payments from drug & device makers
Across 86 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$392
- Collegium Pharmaceutical, Inc.$281
- Pfizer$218
- Globus Medical$180
- Nevro Corp.$167
- AbbVie$114
- plus $378 from 13 others
What the payments were for
- Food & beverage$1,729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $392 |
| Collegium Pharmaceutical, Inc. | 16 | $281 |
| Pfizer | 9 | $218 |
| Globus Medical | 2 | $180 |
| Nevro Corp. | 6 | $167 |
| AbbVie | 7 | $114 |
| Virtus Pharmaceuticals LLC | 3 | $70 |
| Valinor Pharma, LLC | 3 | $65 |
| IBSA Pharma Inc. | 1 | $51 |
| Forte Bio-pharma LLC | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$161
- NURTEC ODT$124
How this compares
$1,729 in reported general payments places this provider in the 70th percentile of 878 medical providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 87 | $225,644 |
| Xtampza ErOxycodone Myristate | 247 | $124,985 |
| Levorphanol Tartrate | 30 | $80,712 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,703 | $64,357 |
| UbrelvyUbrogepant | 26 | $50,730 |
| Nurtec OdtRimegepant Sulfate | 18 | $35,300 |
| OxycontinOxycodone Hcl | 38 | $23,956 |
| HorizantGabapentin Enacarbil | 21 | $20,707 |
| BelbucaBuprenorphine Hcl | 25 | $17,109 |
| Buprenorphine | 53 | $14,683 |
| Nucynta ErTapentadol Hcl | 11 | $13,873 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 333 | $9,906 |
| Oxycodone Hcl | 481 | $9,254 |
| ZtlidoLidocaine | 22 | $8,021 |
| Morphine Sulfate ErMorphine Sulfate | 366 | $7,534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $392 | $225,64487 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er | $281 | $155,966283 claims |
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $70 | $80,71230 claims |
| AbbVieUbrelvy, Savella | $114 | $56,22337 claims |
| PfizerNurtec Odt | $218 | $35,30018 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $21 | $20,70721 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $23 | $8,02122 claims |
| Redhill Biopharma Inc.Movantik | $21 | $6,90818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 878 medical providers in North Carolina.
Other medical in Benson
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.